|
Emil von Behring (Emil Adolf von Behring), as Emil Adolf Behring born (15 March 1854 – 31 March 1917) was a German physiologist who received the 1901 Nobel Prize in Physiology or Medicine, the first one awarded, for his discovery of a diphtheria antitoxin. He was widely known as a "saviour of children," as diphtheria formerly was a major cause of child death.〔(The Immune System: In Defence of our Lives ), nobelprize.org〕 He was ennobled in 1901 for services to medicine. ==Biography== Behring was born ''Adolf Emil Behring'' in Hansdorf (now Ławice, Iława County), Province of Prussia, now Poland. Between 1874 and 1878, he studied medicine at the Akademie für das militärärztliche Bildungswesen, Berlin. He was mainly a military doctor and then became Professor of Hygienics within the Faculty of Medicine at the University of Marburg (against the initial strenuous opposition of the faculty council), a position he would hold for the rest of his life. He and the pharmacologist Hans Horst Meyer had their laboratories in the same building, and Behring stimulated Meyer's interest in the mode of action of tetanus toxin. Behring was the discoverer of diphtheria antitoxin in 1890 and attained a great reputation by that means and by his contributions to the study of immunity. He won the first Nobel Prize in Physiology or Medicine in 1901 for the development of serum therapies against diphtheria (which Kitasato Shibasaburo and Emile Roux also contributed to) and tetanus. The former had been a scourge of the population, especially children, whereas the other was a leading cause of death in wars, killing the wounded. He was elected a Foreign Honorary Member of the American Academy of Arts and Sciences in 1902.〔(【引用サイトリンク】url=http://www.amacad.org/publications/BookofMembers/ChapterB.pdf )〕 At the International Tuberculosis Congress in 1905 he announced that he had discovered "a substance proceeding from the virus of tuberculosis." This substance, which he designated "T C", plays the important part in the immunizing action of Professor Behring's "bovivaccine", which prevents bovine tuberculosis. He tried unsuccessfully to obtain a protective and therapeutic agent for humans.〔Emil von Behring (Serum Therapy in Therapeutics and Medical Science ). Nobel Lecture, December 12, 1901. nobelprize.org〕 He created an antitoxin. Behring demonstrated that the injection of toxins was able to be transmitted to another animal by injections of a treated animal's blood serum and used as a means of effecting a cure. Behring died at Marburg, Hessen-Nassau, on 31 March 1917. His name survived with the Dade Behring, organisation, at the time, the world's largest company dedicated solely to clinical diagnostics, (now part of the Siemens Healthcare Division) in CSL Behring a manufacturer of plasma-derived biotherapies, in Behringwerke AG in Marburg, in Novartis Behring and in the Emil von Behring Prize of the University of Marburg, the highest endowed medicine award in Germany. His Nobel Prize medal is now kept on display at the International Red Cross and Red Crescent Museum in Geneva. Von Behring is believed to have cheated Paul Ehrlich out of recognition and financial reward in relation to collaborative research in diphtheria. The two men developed a diphtheria serum by repeatedly injecting the deadly toxin into a horse. The serum was used effectively during an epidemic in Germany. A chemical company preparing to undertake commercial production and marketing of the diphtheria serum offered a contract to both men, but von Behring maneuvered to claim all the considerable financial rewards for himself. To add insult to injury, only Behring received the first Nobel Prize in Medicine, in 1901, for his contributions. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Emil von Behring」の詳細全文を読む スポンサード リンク
|